openPR Logo
Press release

Uterine Fibroids - Drug Pipeline Landscape, 2022 | Global Insight Services

08-16-2022 09:43 AM CET | Health & Medicine

Press release from: Global Insight Services

Uterine Fibroids - Drug Pipeline Landscape

Uterine Fibroids - Drug Pipeline Landscape

Uterine fibroids are a common type of noncancerous tumor that can grow in and on your uterus. Uterine fibroids are found incidentally during a routine pelvic exam. The causes of fibroids are unknown. Most fibroids happen in people of reproductive age. Possible causes include genetic changes, hormones, other growth factors and extracellular matrix.

Uterine fibroids patients may have symptoms, including excessive or painful m*nstruation, bloating, frequent urination, pain during intercourse, low back pain, constipation, chronic vaginal discharge and increased abdominal distention. Uterine fibroids patients with symptoms may have to take the tests like ultrasound, lab tests and other imaging tests including MRI, hysterosonography, hysterosalpingography and hysteroscopy. Treatment options for uterine fibroids can include over-the-counter (OTC) pain medications, gonadotropin-releasing hormone (GnRH) agonists, iron supplements, oral therapies and birth controls.

Read more about Uterine Fibroids - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/uterine-fibroids-drug-pipeline-landscape-2022/

Report Highlights:

Global Insight Service's, Uterine Fibroids - Drug Pipeline Landscape, 2022 report provides an overview of the Uterine fibroids pipeline drugs. This report covers detailed insights on Uterine Fibroids drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Uterine Fibroids pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31026/

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Endo Pharm
- Jiangsu HengRui Medicine Co., Ltd.
- Kissei Pharmaceutical Co., Ltd.
- Obseva

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31026/

Reasons to Buy:

- Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.
- Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.
- Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.
- Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uterine Fibroids - Drug Pipeline Landscape, 2022 | Global Insight Services here

News-ID: 2705376 • Views:

More Releases from Global Insight Services

Intelligent Document Processing Market to Reach $12.4 Billion by 2034, Growing at 13.5% CAGR | Key Players: Parascript, AntWorks, HyperScience
Intelligent Document Processing Market to Reach $12.4 Billion by 2034, Growing a …
Market Overview Intelligent Document Processing Market is emerging as a cornerstone of digital transformation, helping businesses unlock efficiency by automating document-centric workflows. Valued at $3.5 billion in 2024, it is projected to reach $12.4 billion by 2034, reflecting a strong CAGR of 13.5%. At its core, intelligent document processing (IDP) combines artificial intelligence, machine learning, and natural language processing to capture, extract, and validate data from documents with precision. This innovation
Fiber Optic Connector Market to Expand to $15.2 Billion by 2034, Growing at 10.5% CAGR | Key Players: Furukawa Electric, Sumitomo Electric Industries, HUBER+SUHNER
Fiber Optic Connector Market to Expand to $15.2 Billion by 2034, Growing at 10.5 …
Market Overview Fiber Optic Connector Market is undergoing rapid growth as demand for faster, more reliable communication networks accelerates globally. Valued at $5.6 billion in 2024, the market is projected to reach $15.2 billion by 2034, growing at a CAGR of 10.5%. Fiber optic connectors are critical components that enable seamless optical signal transmission in applications ranging from telecommunications and data centers to aerospace, healthcare, and industrial automation. With the rise
Massive Open Online Course Market to Skyrocket to $75 Billion by 2034 at 20.6% CAGR | Key Players: Coursera, edX, Udacity
Massive Open Online Course Market to Skyrocket to $75 Billion by 2034 at 20.6% C …
Market Overview Massive Open Online Course Market is rapidly reshaping the global education landscape by making high-quality learning accessible to anyone with an internet connection. In 2024, the market was valued at $11.5 billion and is projected to reach $75 billion by 2034, growing at an impressive CAGR of 20.6%. MOOCs provide diverse offerings, from free introductory courses to professional certificates and full degree programs. With the rise of AI-driven personalization,
Ophthalmic Drugs Market to Surpass $68.7 Billion by 2034, Growing at 5.9% CAGR | Key Players: Regeneron Pharmaceuticals, Allergan, Novartis
Ophthalmic Drugs Market to Surpass $68.7 Billion by 2034, Growing at 5.9% CAGR | …
Market Overview Ophthalmic Drugs Market is undergoing significant expansion, reflecting rising global health concerns around eye-related conditions. In 2024, the market was valued at $38.9 billion and is projected to reach $68.7 billion by 2034, growing at a CAGR of 5.9%. This growth is largely driven by an aging population, increasing incidence of eye disorders, and advancements in treatment options. The market covers a wide range of prescription and over-the-counter medications

All 5 Releases


More Releases for Uterine

Uterine Fibroids Symptoms
USA Fibroids Center is here to offer detailed information on https://www.usafibroidcenters.com/blog/uterine-fibroids-symptoms/ and help you discuss the best treatments for uterine fibroids at the clinic. Find out the best Fibroid Treatment for you! Treatments for uterine fibroids are accessed in women with problems related to them and show symptoms such as heavy menstrual bleeding, pain or pressure in the pelvis, or infertility and sterility.
Bharath Hospital Kottayam Offers Minimally Invasive Treatment for Uterine Fibroi …
Bharath Hospital Kottayam is excited introduce the latest advancement in women's healthcare - the Uterine Fibroid Embolization (UFE) treatment. Uterine fibroids are non-cancerous growths that form in the uterus. They are a common condition among women, especially those of reproductive age. These tumors can vary in size, from small growths to large masses that can distort the shape of the uterus. Although many women with uterine fibroids experience no symptoms,
Uterine Manipulator Devices Market Report 2018: Segmentation by Type (Donnez Typ …
Global Uterine Manipulator Devices market research report provides company profile for ConMed, Richard Wolf, Bisinger, Planmeca Oy, Ethicon Endosurgery, Cooper Surgical, Hospiiniz International, C. R. Bard and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Uterine Fibroids Treatment Market : Hysterectomy to Remain Most Preferred Uterin …
The market for uterine fibroids treatment market is fragmented in nature with a high number of players operating in it across the U.S., states a new market research report by Transparency Market Research. The estimated entry of new players and the increasing research and development activities are some of the key factors that are projected to strengthen the competitive scenario of the market throughout the forecast period. The leading players
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018 - Research By Ma …
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) pipeline landscape. Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers
Uterine Fibroids Treatment Market: Rising Prevalence of Uterine Fibroids amongst …
The high prevalence of uterine fibroids across the U.S. has created a significant demand for uterine fibroid treatments across the countries. The growing public concern about the occurrence of uterine fibroids, which are also called uterine leiomyoma, have propelled the demand for treatments and solutions to alleviate the pain, excessive bleeding, and pelvic discomfort. According to the report by Transparency Market Research, the U.S. uterine fibroid treatment market is anticipated to